The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

AstraZeneca PLC ADR closed $9.15 short of its 52-week high ($87.68), which the company reached on August 30th.

Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca ...

The AstraZeneca PLC ADR AZN inched 0.98% higher to $79.04 Monday, on what proved to be an all-around mixed trading session ...

A healthy 27-year-old died from a reaction to the AstraZeneca Covid vaccine after NHS mistakes meant he wrongly got the jab, ...

The most recent trading session ended with Astrazeneca (AZN) standing at $78.38, reflecting a -0.66% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's ...

AstraZeneca's Dato-DXd faces challenges in overall survival data but holds potential for approval with promising PFS benefits ...

AstraZeneca is continuing to study AZD8205 as a monotherapy in dose optimization expansion cohorts of patients with ...

AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...

If the trial design doesn't cause regulatory issues, the results could reshape how muscle-invasive bladder tumors are treated ...

Approvals are coming fast and furious for Johnson & Johnson’s Rybrevant as it is lining up to challenge the dominance of ...